Clinical Trial Update: Effectiveness and Efficiency of a Voriconazole Preemptive Genotyping Strategy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing effectiveness and efficiency of a voriconazole preemptive genotyping strategy for invasive fungal infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infections

Drugs mentioned

• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Invasive Fungal Infections | Phase 4 | Status: UNKNOWN